1. Homocysteine and Gliotoxicity.
- Author
-
Wyse ATS, Bobermin LD, Dos Santos TM, and Quincozes-Santos A
- Subjects
- Animals, Astrocytes drug effects, Astrocytes metabolism, Astrocytes pathology, Gliosis chemically induced, Gliosis metabolism, Gliosis pathology, Humans, Hyperhomocysteinemia chemically induced, Hyperhomocysteinemia metabolism, Hyperhomocysteinemia pathology, Neurodegenerative Diseases pathology, Neuroglia pathology, Homocysteine metabolism, Homocysteine toxicity, Neurodegenerative Diseases chemically induced, Neurodegenerative Diseases metabolism, Neuroglia drug effects, Neuroglia metabolism
- Abstract
Homocysteine is a sulfur amino acid that does not occur in the diet, but it is an essential intermediate in normal mammalian metabolism of methionine. Hyperhomocysteinemia results from dietary intakes of Met, folate, and vitamin B12 and lifestyle or from the deficiency of specific enzymes, leading to tissue accumulation of this amino acid and/or its metabolites. Severe hyperhomocysteinemic patients can present neurological symptoms and structural brain abnormalities, of which the pathogenesis is poorly understood. Moreover, a possible link between homocysteine (mild hyperhomocysteinemia) and neurodegenerative/neuropsychiatric disorders has been suggested. In recent years, increasing evidence has emerged suggesting that astrocyte dysfunction is involved in the neurotoxicity of homocysteine and possibly associated with the physiopathology of hyperhomocysteinemia. This review addresses some of the findings obtained from in vivo and in vitro experimental models, indicating high homocysteine levels as an important neurotoxin determinant of the neuropathophysiology of brain damage. Recent data show that this amino acid impairs glutamate uptake, redox/mitochondrial homeostasis, inflammatory response, and cell signaling pathways. Therefore, the discussion of this review focuses on homocysteine-induced gliotoxicity, and its impacts in the brain functions. Through understanding the Hcy-induced gliotoxicity, novel preventive/therapeutic strategies might emerge for these diseases.
- Published
- 2021
- Full Text
- View/download PDF